Talk:Intramyocellular lipids
Add topic | This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||
| ||||||||||||||
_active.jpg)
from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971250/ "muscle insulin resistance and mitochondrial dysfunction in advanced obesity, T2D and aging may reverse the course causing imcTG to accumulate,". Factchecker170 (talk) 04:56, 6 October 2015 (UTC)
Questionable sources
[edit]References 4-7 seem to be a bit lacking. 3 of them don't even have a page number listed. Very hard to verify that the sources say what the editor claims they say. Is there a proper process for determining if sources are credible? Factchecker170 (talk) 18:59, 30 April 2019 (UTC)
Misplaced reference
[edit]Reference №3 appears to support the opposite of the claim it's cited at, namely that it's just a marker instead of a causal factor. Even just the title of the paper "Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion" seems to make abundantly clear the causal link between imcTG and insulin resistance or what am I missing 2003:C3:9718:F400:B159:56D7:D380:90DE (talk) 12:30, 28 April 2020 (UTC)